Tuesday, February 7, 2017

Trump backs negotiating drug prices under Medicare: White House

Medications/Drugs News Headlines - Yahoo! News
Trump backs negotiating drug prices under Medicare: White House

FILE PHOTO: U.S. President-elect Donald Trump speaks at his election night rally in ManhattanPresident Donald Trump supports the government negotiating directly with drug companies on prices for drugs covered by the Medicare insurance program, the White House said on Tuesday. "He's for it," White House spokesman Sean Spicer said, when asked at a briefing whether Trump still supports negotiating drug prices for the healthcare program. Spicer said Trump was committed to using his "skills as a businessman" to drive prices down.


Teva CEO exits in ongoing crisis of confidence at drugmaker

Erez Vigodman, President and CEO of Teva Pharmaceutical, participates in a panel discussion at the 2015 Fortune Global Forum in San FranciscoTeva Pharmaceutical Industries was left without a permanent chief executive on Tuesday after Erez Vigodman stepped down, leaving new management to restore confidence in the world's biggest generic drugmaker after a series of missteps. Teva, Israel's largest company, said late on Monday that Vigodman was departing immediately and would be replaced on an interim basis by Chairman Yitzhak Peterburg. Investors say Teva, which faces pricing pressure in its core generics business and recently lost patent protection on its key branded drug Copaxone for multiple sclerosis, must choose a new CEO with extensive pharmaceutical experience.


Carmat withdraws initial request to resume artificial heart implants
(Reuters) - Artificial heart maker Carmat said on Monday it had decided to withdraw its initial request to France's national drugs agency (ANSM) to resume trial implantations. ANSM ordered Carmat in December to suspend further implantations following the death of a fifth patient in October. "The patient’s death was due to an interruption in the power supply system, following incorrect battery handling by the patient, as a result of which the prosthesis stopped functioning," Carmat said.

No comments:

Post a Comment